Pins matching tag:Guidance

Johnson & Johnson reported second-quarter sales of $25.3 billion, up 6.6%, and adjusted EPS of $2.90, and raised its 2026 outlook to about $101.1 billion in sales and $11.68 adjusted EPS at the midpoint.

TSMC reported second-quarter revenue of US$40.20 billion, up 33.7% from a year earlier, a 67.7% gross margin and record net income of NT$706.56 billion, guided Q3 revenue to US$44.6-45.8 billion and raised its 2026 capital budget to US$60-64 billion.

Abbott posted second-quarter sales of $12.59 billion, up 13.0% reported and 4.8% comparable, and adjusted EPS of $1.31, and raised its 2026 adjusted EPS guidance to $5.45 to $5.60.

On 21 July 2026 GM reported second-quarter revenue of US$48.0 billion, EBIT-adjusted of US$3.9 billion and net income of US$1.3 billion, and raised its 2026 EBIT-adjusted guidance to US$14.0-16.0 billion.

On 22 July 2026 Texas Instruments reported second-quarter revenue of US$5.46 billion, up 23% from a year earlier, with net income of US$1.98 billion and earnings per share of US$2.14, and guided third-quarter revenue to US$5.65-6.15 billion.

On 24 July 2026 NextEra Energy reported second-quarter adjusted earnings of US$2.407 billion, or US$1.15 a share, against US$1.05 a year earlier, and kept its 2026 adjusted EPS outlook at US$3.92 to US$4.02.

On 28 July 2026 Ford reported second-quarter revenue of US$48.3 billion and adjusted EBIT of US$2.5 billion, took a net loss of US$1.3 billion on the BlueOval SK joint-venture disposition, and lifted full-year adjusted EBIT guidance to US$10 billion to US$11 billion.

On 28 July 2026 UPS reported second-quarter revenue of US$22.8 billion and adjusted earnings of US$1.76 a share, and raised its full-year revenue outlook to about US$91.2 billion after completing its Amazon glide-down.

On 30 July 2026 Sanofi reported second-quarter sales up 17.8% at constant rates to EUR 11.6 billion and business EPS of EUR 2.09, and raised its 2026 outlook to about 10% sales growth.

Hershey's second-quarter adjusted EPS rose 57% to $1.90 and net sales 6.6% to $2.79 billion as 12 points of price outweighed an 8-point volume drop, and it narrowed its 2026 outlook upward to 32.5-35% adjusted EPS growth.

On 4 August 2026 Merck reported second-quarter sales of US$16.6 billion, up 5 percent, with Keytruda at US$8.4 billion, and raised its 2026 sales outlook while a US$2.31 per share Terns charge caused a loss.

On 4 August 2026 Pfizer reported second-quarter revenue of US$15.0 billion, adjusted EPS of US$0.77 and a US$4.3 billion impairment charge, and raised full-year revenue guidance by US$500 million.

On 4 August 2026 Novo Nordisk reported Q2 adjusted sales up 7% and adjusted operating profit up 11% at constant exchange rates and raised its 2026 outlook to 0% to -6%, helped by stronger GLP-1 sales.

On 6 August 2026 Constellation reported adjusted operating earnings of US$2.55 per share for the second quarter and raised its 2026 guidance range to US$11.50 to US$12.50 per share.

On 19 August 2026 Target reported second-quarter net sales up 5.3% to US$26.5 billion, comparable sales up 3.8% and EPS of US$4.11, including a US$994 million pretax tariff refund benefit, and raised its full-year guidance.

On 20 August 2026 Walmart reported second-quarter fiscal 2027 revenue of US$187.9 billion, up 5.9%, with eCommerce up 23% and nearly US$2.9 billion in tariff refunds, but shares fell sharply after the EPS outlook missed estimates.

On 1 September 2026 Dell Technologies reported second-quarter fiscal 2027 revenue of US$47.0 billion, up 58%, with US$16.4 billion of AI server revenue, and raised its full-year revenue guidance to US$192 billion.

HPE posted record fiscal third-quarter revenue of $12.2 billion, up 34%, and non-GAAP EPS of $1.11, then raised its fiscal 2026 and 2027 outlook as AI and networking orders ran ahead of memory-constrained supply.

Johnson & Johnson releases its third-quarter 2026 results at about 6:45 a.m. Eastern on Tuesday 13 October and reviews them on an 8:30 a.m. investor call hosted by CEO Joaquin Duato and CFO Joseph Wolk.

TSMC reports third-quarter 2026 results and gives its fourth-quarter outlook at its earnings conference on Thursday 15 October at 2 p.m. Taiwan time, against its own guidance of US$44.6-45.8 billion in revenue and a 65-67% gross margin.

Abbott reported US$13.013 billion in third-quarter sales, up 14.5%, and adjusted diluted EPS of US$1.42. It forecasts about 6% comparable sales growth for 2026 and tightened adjusted EPS guidance to US$5.50–5.55.

Hershey's third-quarter 2026 results, the first test of its narrowed outlook for 4.5-5% sales growth and a 32.5-35% rebound in adjusted earnings per share as cocoa costs ease.

Eli Lilly is expected to report third-quarter 2026 results on 29 October, with its usual 10 a.m. ET conference call. It goes in guiding to $85-87 billion of 2026 revenue after second-quarter revenue jumped 48% to $23.0 billion on Mounjaro and Zepbound.

No official date is set, but Nasdaq's earnings calendar projects ThredUp will report third-quarter 2026 results around November 2, 2026, after the company trimmed its second-half outlook on its Q2 call over price-sensitive buyers.

HPE is expected to report fiscal Q4 and full-year 2026 results after the close, most likely on Thursday 3 December, having guided to $13.9-14.8 billion of quarterly revenue and $1.20-1.30 of non-GAAP EPS; HPE has not yet announced the date.

Johnson & Johnson holds its first enterprise business review since December 2023, where CFO Joseph Wolk says it will set out growth above its 5% to 7% long-term target, with a clear line of sight to double digits by the end of the decade.

On Holding is expected to report fourth-quarter and full-year 2026 results in early March 2027, when it must reiterate or reset guidance of low-20% constant-currency growth, a gross margin of at least 65.0% and an adjusted EBITDA margin of 19.5%-20.0%.